In keeping with this, up-regulated TG2 mRNA and a corresponding increase in protein level and enzymatic activity have been observed in many neurodegenerative diseases, including Alzheimer’s (AD), Parkinson’s (PD), Huntington’s (HD), and other polyglutamine expansion disorders [5,113]. This evidence concerns the gene TGM2 and Parkinson disease.